Three Appointments to Héma-Québec’s Board of Directors 

Montréal, February 19, 2026 – On February 11, the Québec government’s Cabinet appointed three new members to Héma-Québec’s Board of Directors: Nicolas Bergeron, Dr. Pierre-Aurèle Morin and France Bourdeau. In addition, Dr. Patricia Pelletier, who has served as a board member since 2017, has been reappointed for another term.

Nicolas Bergeron

An income tax auditor with the Canada Revenue Agency, Nicolas Bergeron has also served since 2023 as an ambassador for the youth division of the Association des bénévoles du don de sang (ABDS). He holds a Bachelor of Commerce from Concordia University and will represent donors and volunteers on the Board.

Pierre-Aurèle Morin, MD, FRCPC, DRCPSC 

Director of Blood Banks and Head of the Transfusion Medicine Department at the CIUSSS de l’Estrie–CHUS, Dr. Morin is also an Assistant Professor in the Department of Medicine at the Université de Sherbrooke. He serves on various education-related committees, including the hematology residency program competence committee, which he has chaired since 2022. He is also actively involved in research, both as a supervisor and as the author of several publications, and has been a member of Québec’s Comité de biovigilance since 2022.

France Bourdeau, CPA, CA, IAS.A 

A corporate director, France Bourdeau brings more than 30 years of international experience in financial management and leadership across a range of sectors, including finance, insurance, consulting services, manufacturing, events and technology. She will represent the business community on the Board.

Patricia Pelletier, MD

Dr. Patricia Pelletier is a hematologist at the McGill University Health Centre and Head of the Transfusion Medicine Department at Optilab Montréal–MUHC. An Associate Professor in the Faculty of Medicine and Health Sciences at McGill University, she also serves on several provincial committees related to transfusion medicine, as well as on the National Advisory Committee on Blood and Blood Products.

About Héma-Québec’s Board of Directors 

Héma-Québec’s activities are overseen by a Board of Directors composed of members who collectively provide a balanced mix of experience and expertise aligned with the organization’s operations and stakeholders, particularly in transfusion and collection activities.

Board members are appointed from categories set out in the Loi sur Héma-Québec et le Comité de biovigilance, including recipients of blood products, donors and volunteers, the research community, the public health sector and the business community, among others. Members are appointed for four-year terms.